Tag: high throughput screening hts market outlook

  • High Throughput Screening (HTS) Market Growth To $38.33 Billion Creates New Opportunities Across The Industry

    High Throughput Screening (HTS) Market Growth To $38.33 Billion Creates New Opportunities Across The Industry

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    High Throughput Screening (HTS) Market Forecast: What Value Will The Market Reach By 2030?

    The high throughput screening (hts) market size has experienced substantial growth in recent years. This market is forecasted to increase from $25.26 billion in 2025 to $27.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. Historically, this growth can be ascribed to a rising demand for swift drug discovery, progress in assay technologies, increased pharmaceutical R&D investments, the growing incorporation of robotics in laboratories, and the expansion of contract research organizations.

    The high throughput screening (hts) market is poised for significant expansion in the next few years. It is projected to reach $38.34 billion in 2030, growing at a compound annual growth rate (CAGR) of 8.7%. This anticipated growth throughout the forecast period is attributable to elements such as the integration of AI and machine learning in hts, the increasing prevalence of personalized medicine, a rise in investments targeting biotechnology startups, the broadening of emerging markets in Asia-Pacific, and advancements in multiplexed and label-free assay technologies. Furthermore, prominent trends anticipated during this period include the incorporation of high-throughput automation, the miniaturization of screening platforms, the advent of advanced detection technologies, the ongoing development of multiplexed assays, and the implementation of cloud-based data management solutions.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=32782795&type=smp&name=High%20Throughput%20Screening%20%28HTS%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    High Throughput Screening (HTS) Market Growth Backed By Core Demand Fundamentals

    The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the high-throughput screening (HTS) market in the future. A chronic disease is defined as a health ailment or condition that endures for an extended duration, generally exceeding three months. HTS facilitates the swift evaluation of numerous chemical substances to identify prospective drug candidates that target particular pathways or mechanisms involved in chronic diseases, which is crucial for managing them effectively over the long term. For example, data from January 2023, provided by the National Library of Medicine, a US-based government agency, projects that the population in the US aged 50 and older suffering from at least 1 chronic condition will rise to 142.66 million by the year 2050. Consequently, the escalating incidence of chronic diseases is set to stimulate growth in the high-throughput screening (HTS) market.

    High Throughput Screening (HTS) Market Segmentation And Category Overview

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    High Throughput Screening (HTS) Market Growth Trends Reshaping The Competitive Landscape

    Leading companies within the high-throughput screening market are actively developing innovative products, such as multimode plate readers, to better serve their customers with advanced functionalities. A multimode plate reader (MPR) represents a sophisticated laboratory tool utilized in high-throughput screening, enabling the analysis of biological and chemical samples within microplates by integrating multiple detection modes for diverse assays on a single platform. For example, in February 2023, PerkinElmer Inc., a US-based MedTech company, introduced its EnVision Nexus system. The EnVision Nexus system distinguishes itself as the fastest and most sensitive multimode plate reader available, specifically engineered for demanding high-throughput screening (HTS) applications to accelerate drug discovery initiatives. Through its unique technology, which includes dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, combined with the newest reagent kits, the platform delivers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with convenient walkaway options such as a plate stacker for 20 or 50 plates, or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with exceptional productivity.

    High Throughput Screening (HTS) Market Competitive Analysis Of Leading Industry Participants

    Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

    View The Full High Throughput Screening (HTS) Market Report:

    https://thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    High Throughput Screening (HTS) Market Global Footprint: Which Region Leads The Market?

    North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • High Throughput Screening (HTS) Market Expansion Is Opening New Pathways For Strategic Investment

    High Throughput Screening (HTS) Market Expansion Is Opening New Pathways For Strategic Investment

    Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

    High Throughput Screening (HTS) Market Size And Revenue Forecast Through 2030

    The high throughput screening (HTS) market has seen significant expansion in recent years, with projections indicating it will rise from $25.26 billion in 2025 to $27.47 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.7%. This historic growth is driven by factors such as a growing need for faster drug discovery, progress in assay technologies, increased spending on pharmaceutical research and development, greater use of robotics in lab settings, and the expanding role of contract research organizations.

    The high throughput screening (HTS) market is projected to experience robust expansion over the coming years, reaching an estimated $38.34 billion by 2030, driven by a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is fueled by several key factors, including the incorporation of artificial intelligence and machine learning into HTS processes, the rise of personalized medicine, increased funding for biotechnology startups, the growing influence of emerging markets in the Asia-Pacific region, and the creation of multiplexed and label-free assay technologies. Notable trends shaping the forecast period encompass the integration of high-throughput automation, the downsizing of screening platforms, the adoption of advanced detection methods, the development of multiplexed assays, and the use of cloud-based data management systems.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

    High Throughput Screening (HTS) Market Demand Drivers: What Is Fueling Industry Growth?

    The anticipated expansion of the high-throughput screening (HTS) market is being driven by the growing occurrence of chronic diseases. Chronic diseases are defined as health conditions that persist for an extended duration, generally three months or longer. High-throughput screening facilitates the swift evaluation of a large number of chemical compounds to identify potential drug candidates that act on specific pathways or mechanisms related to chronic diseases, which is crucial for their sustained management. For example, the National Library of Medicine, a US government agency, reported in January 2023 that the population of Americans aged 50 and above with at least one chronic condition is projected to reach 142.66 million by 2050. Consequently, the increasing prevalence of chronic diseases is set to propel the high-throughput screening (HTS) market forward.

    High Throughput Screening (HTS) Market Segment Analysis And Revenue Opportunities

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    High Throughput Screening (HTS) Market Innovation Trends: Which Developments Are Transforming The Industry?

    Leading players in the high-throughput screening space are introducing cutting-edge solutions, including multimode plate readers, designed to deliver enhanced capabilities to their clientele. A multimode plate reader (MPR) functions as an advanced laboratory instrument employed in high-throughput screening to assess biological and chemical specimens within microplates, merging several detection techniques for a variety of assays on a single system. Take February 2023 as an example: PerkinElmer Inc., a MedTech company headquartered in the US, unveiled the EnVision Nexus system. This system is recognized as the quickest and most sensitive multimode plate reader available, purpose-built for rigorous high-throughput screening (HTS) applications aimed at speeding up drug discovery processes. Leveraging distinctive technology such as dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, along with updated reagent kits, the platform provides researchers with exceptional assay adaptability, precision, speed, and sensitivity. Offering hands-free convenience through options like a plate stacker holding 20 or 50 plates, or full automation and integration for uninterrupted 24/7 workflow-driven operations, the EnVision Nexus system enables researchers to screen millions of samples with remarkable efficiency.

    High Throughput Screening (HTS) Market Leading Players Shaping Industry Direction

    Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

    Access The Complete High Throughput Screening (HTS) Market Report:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

    High Throughput Screening (HTS) Market Regional Outlook: Where Are The Largest Opportunities Located?

    North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Growing Prevalence Of Chronic Diseases Fuels High-Throughput Screening Market Expansion Is Supporting Development Across The High Throughput Screening (HTS) Market

    Growing Prevalence Of Chronic Diseases Fuels High-Throughput Screening Market Expansion Is Supporting Development Across The High Throughput Screening (HTS) Market

    The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

    What Are The Forecasted Market Size Figures For The High Throughput Screening (HTS) Market In 2026 And 2030?

    The high throughput screening (hts) market size has experienced significant expansion over recent years. Forecasts indicate it will expand from $25.26 billion in 2025 to $27.47 billion in 2026, driven by a compound annual growth rate (CAGR) of 8.7%. This historical growth can be attributed to several factors, including an escalating demand for rapid drug discovery, continuous advancements in assay technologies, increased investments in pharmaceutical R&D, a growing adoption of robotics within laboratories, and the widespread expansion of contract research organizations.

    The high throughput screening (hts) market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $38.34 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.7%. This forecasted growth is largely driven by factors such as the incorporation of AI and machine learning into hts, the increasing prevalence of personalized medicine, a surge in investments towards biotechnology startups, the expansion of nascent markets in the Asia-Pacific region, and advancements in multiplexed and label-free assay technologies. Significant trends anticipated during this period encompass the integration of high-throughput automation, the shrinking size of screening platforms, sophisticated detection technologies, the creation of multiplexed assays, and cloud-based systems for data management.

    Download A Free Sample Report For Comprehensive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    What Influential Factors Are Boosting The High Throughput Screening (HTS) Market Demand?

    The increasing prevalence of chronic diseases is projected to propel the expansion of the high-throughput screening (HTS) market moving forward. A chronic disease is characterized as a long-term health condition or illness that persists for an extended period, typically three months or more. HTS enables the rapid evaluation of numerous chemical compounds to identify potential drug candidates targeting specific pathways or mechanisms linked to chronic conditions, which is vital for their effective long-term management. For instance, in January 2023, the National Library of Medicine, a US-based government agency, reported that the number of people in the US aged 50 and older who have at least 1 chronic condition is expected to rise to 142.66 million by 2050. Therefore, the growing incidence of chronic diseases will drive the growth of the high-throughput screening (HTS) market.

    What Segment Categories Are Evaluated In The High Throughput Screening (HTS) Market Study?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    What Trends Are Shaping The High Throughput Screening (HTS) Market Structure?

    Leading companies operating within the high-throughput screening market are developing innovative products, such as multimode plate readers, to better cater to their customers with advanced functionalities. A multimode plate reader (MPR) is an advanced laboratory tool employed in high-throughput screening, analyzing biological and chemical specimens in microplates by integrating multiple detection modes for diverse assays on a unified platform. For example, in February 2023, PerkinElmer Inc., a US-based MedTech company, launched the EnVision Nexus system. The EnVision Nexus system stands out as the fastest and most sensitive multimode plate reader on the market, expressly designed for demanding high-throughput screening (HTS) applications to speed up drug discovery efforts. Featuring its unique technology, which includes dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, combined with the latest reagent kits, the platform offers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with convenient walkaway options like a plate stacker for 20 or 50 plates, or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with exceptional efficiency.

    Who Are The Firms Contributing To The High Throughput Screening (HTS) Market Ecosystem?

    Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

    Access The Complete High Throughput Screening (HTS) Market Report:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Which Region Stands As The Largest Contributor To The High Throughput Screening (HTS) Market?

    North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Access High Throughput Screening (HTS) Market Report for Deeper Competitive Insights

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company

    High Throughput Screening Hts Market Report 2026

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Carrier Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

    Herg Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Growth In The High Throughput Screening (HTS) Market Is Being Driven By Chronic Disease Epidemic Is A Catalyst For The Surge In Acute Ischemic Stroke Drug Growth

    Growth In The High Throughput Screening (HTS) Market Is Being Driven By Chronic Disease Epidemic Is A Catalyst For The Surge In Acute Ischemic Stroke Drug Growth

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Level Of Market Value Growth Is Predicted For The High Throughput Screening (HTS) Market From 2026 To 2030?

    The high throughput screening (hts) market size has experienced significant expansion in recent years. It is forecast to rise from $25.26 billion in 2025 to $27.47 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. This growth in prior periods stemmed from factors such as increasing demand for rapid drug discovery, advancements in assay technologies, growth in pharmaceutical R&D investments, rising adoption of robotics in laboratories, and the expansion of contract research organizations.

    The high throughput screening (hts) market size is anticipated to experience substantial growth in the upcoming years, projected to reach $38.34 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is driven by factors such as the integration of AI and machine learning into hts, the advancement of personalized medicine, increased investments in biotechnology startups, the broadening of emerging markets in Asia-Pacific, and the innovation in multiplexed and label-free assay technologies. Prominent trends expected in this period encompass high-throughput automation integration, the miniaturization of screening platforms, sophisticated detection technologies, the development of multiplexed assays, and cloud-based data management.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    Which Key Drivers Are Affecting The High Throughput Screening (HTS) Market Development?

    The increasing incidence of chronic illnesses is anticipated to propel the expansion of the high-throughput screening (HTS) market moving forward. A chronic disease is defined as a health ailment or condition that endures for an extended duration, generally three months or longer. HTS facilitates the swift examination of many chemical compounds to identify promising drug candidates that target particular pathways or mechanisms involved in chronic diseases, which is crucial for managing them effectively over the long term. As an illustration, the National Library of Medicine, a US-based government agency, reported in January 2023 that the population in the US aged 50 and older with at least 1 chronic condition is projected to reach 142.66 million by 2050. Consequently, the expanding prevalence of chronic diseases will stimulate the growth of the high-throughput screening (HTS) market.

    What Segment Categories Shape The High Throughput Screening (HTS) Market Segment Landscape?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    Which Trends Are Contributing To Changes In The High Throughput Screening (HTS) Market?

    Leading companies in the high-throughput screening market are developing innovative products, such as multimode plate readers, to better serve their customers with advanced functionalities. A multimode plate reader (MPR) is a sophisticated laboratory instrument utilized in high-throughput screening for analyzing biological and chemical samples within microplates, achieved by integrating multiple detection modes for diverse assays onto a single platform. For instance, in February 2023, PerkinElmer Inc., a US-based MedTech company, introduced the EnVision Nexus system. This system is noted as the fastest and most sensitive multimode plate reader available, specifically engineered for demanding high-throughput screening (HTS) applications to expedite drug discovery efforts. Through its unique technology, which includes dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, along with the latest reagent kits, the platform offers researchers exceptional assay flexibility, accuracy, speed, and sensitivity. Equipped with walkaway convenience options such as a plate stacker for 20 or 50 plates or full automation and integration for continuous 24/7 workflow operations, the EnVision Nexus system enables researchers to efficiently screen millions of samples with remarkable efficiency.

    Who Are The Companies Operating Across The High Throughput Screening (HTS) Market Value Chain?

    Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

    Get The Full High Throughput Screening (HTS) Market Report:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Where Is The High Throughput Screening (HTS) Market Primarily Concentrated By Region?

    North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized High Throughput Screening (HTS) Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company

    High Throughput Screening Hts Market Report 2026

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Carrier Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

    Herg Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • High Throughput Screening (HTS) Industry Forecast Indicating Market Size of $38.34 Billion by 2030 at 8.7% CAGR

    High Throughput Screening (HTS) Industry Forecast Indicating Market Size of $38.34 Billion by 2030 at 8.7% CAGR

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    What Market Size Growth Is Projected For The High Throughput Screening (HTS) Market During The Forecast Period 2026–2030?

    The high throughput screening (hts) market has experienced robust expansion in recent years. It is projected to increase from $25.26 billion in 2025 to $27.47 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.7%. This historical growth can be attributed to an escalated demand for swift drug discovery, advancements in assay technologies, increased investments in pharmaceutical R&D, the growing integration of robotics in laboratory environments, and the expansion of contract research organizations.

    The high throughput screening (hts) market size is projected to experience robust expansion over the coming years. It is anticipated to grow to $38.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This growth during the forecast period can be attributed to the integration of AI and machine learning into hts, the increasing prevalence of personalized medicine, rising investments in biotechnology startups, the expansion of emerging markets in Asia-Pacific, and the development of multiplexed and label-free assay technologies. Major trends expected in this period include the integration of high-throughput automation, the miniaturization of screening platforms, advanced detection technologies, the advancement of multiplexed assay development, and the adoption of cloud-based data management.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    Which Major Factors Are Driving The Expansion Of The High Throughput Screening (HTS) Market?

    The high-throughput screening (HTS) market is anticipated to expand due to the increasing prevalence of chronic diseases. A chronic disease is defined as a long-lasting health condition or ailment that endures for an extended period, generally three months or more. HTS facilitates the quick assessment of numerous chemical compounds to identify potential drug candidates targeting specific pathways or mechanisms related to chronic diseases, which is vital for their effective long-term treatment. For instance, in January 2023, the National Library of Medicine, a US-based government agency, reported that the count of individuals in the US aged 50 and older suffering from at least one chronic condition is expected to rise to 142.66 million by 2050. Hence, the growing incidence of chronic diseases will propel the high-throughput screening (HTS) market’s growth.

    What Market Segments Are Evaluated Within The High Throughput Screening (HTS) Market?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    What Industry Trends Are Redefining The High Throughput Screening (HTS) Market?

    Leading firms in the high-throughput screening market are introducing innovative solutions, like multimode plate readers, to provide customers with enhanced functionalities. A multimode plate reader (MPR) serves as a sophisticated laboratory instrument for high-throughput screening, enabling the analysis of biological and chemical samples in microplates by combining various detection modes for a wide range of assays on one platform. An example is PerkinElmer Inc., a US-based MedTech company, which unveiled the EnVision Nexus system in February 2023. The EnVision Nexus system is recognized as the quickest and most sensitive multimode plate reader accessible, specifically engineered for challenging high-throughput screening (HTS) applications to accelerate drug discovery initiatives. Its distinct technology, comprising dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, along with current reagent kits, furnishes researchers with unmatched flexibility, precision, speed, and sensitivity in assays. Featuring walkaway convenience options, including a plate stacker for 20 or 50 plates, or complete automation and integration for nonstop 24/7 workflow operations, the EnVision Nexus system allows researchers to effectively screen millions of samples with exceptional efficiency.

    Who Are The Top Market Participants Influencing The High Throughput Screening (HTS) Market?

    Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

    Read the full high throughput screening (hts) market report here:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Which Region Currently Holds The Largest Share Of The High Throughput Screening (HTS) Market?

    North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored High Throughput Screening (HTS) Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company

    High Throughput Screening Hts Market Report 2026

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Carrier Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

    Herg Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • High Throughput Screening (HTS) Market Growth Projection: Expected to Surpass $38.34 Billion by 2030 at 8.7% CAGR

    High Throughput Screening (HTS) Market Growth Projection: Expected to Surpass $38.34 Billion by 2030 at 8.7% CAGR

    Uncover key drivers, emerging technologies, and competitive movements shaping the high throughput screening (hts) market from 2026–2035 with trusted insights from The Business Research Company

    What was the valuation of the High Throughput Screening (HTS) Market in 2026, and what figure is it projected to hit by 2030?

    The high throughput screening (hts) market size has experienced significant growth over recent years. It is anticipated to increase from $25.26 billion in 2025 to $27.47 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.7%. The expansion observed in the past can be credited to factors such as a rising demand for expedited drug discovery, innovations in assay technologies, an uptick in pharmaceutical R&D investments, the growing incorporation of robotics in laboratories, and the wider reach of contract research organizations.

    The market for high throughput screening (hts) is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $38.34 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.7%. This growth during the forecast timeframe stems from factors such as the incorporation of AI and machine learning into hts, the proliferation of personalized medicine, increasing capital flowing into biotechnology startups, the widening of emerging markets, particularly in Asia-Pacific, and the advancement of multiplexed and label-free assay technologies. Key trends expected within the forecast period encompass the integration of high-throughput automation, the reduction in size of screening platforms, sophisticated detection technologies, the creation of multiplexed assays, and cloud-enabled data management systems.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    Which Drivers Are Affecting Market Participation In The High Throughput Screening (HTS) Market?

    An anticipated increase in chronic disease prevalence is set to drive the expansion of the high-throughput screening (HTS) market. Chronic diseases are defined as health conditions that endure over an extended duration, usually exceeding three months. HTS facilitates the swift evaluation of numerous chemical compounds to identify promising drug candidates that target specific pathways or mechanisms associated with chronic diseases, crucial for their effective long-term management. As an illustration, the National Library of Medicine, a US government agency, reported in January 2023 that the population in the US aged 50 and above with at least one chronic condition is projected to reach 142.66 million by 2050. Consequently, the growing occurrence of chronic diseases will fuel the expansion of the high-throughput screening (HTS) market.

    What Segment Categories Are Covered In The High Throughput Screening (HTS) Market?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    How Are Emerging Trends Affecting The Progression Of The High Throughput Screening (HTS) Market?

    Leading firms in the high-throughput screening market are creating cutting-edge products, including multimode plate readers, to provide enhanced features and improved service to their clientele. A multimode plate reader (MPR) serves as a sophisticated laboratory instrument utilized in high-throughput screening for the analysis of biological and chemical samples within microplates, achieving this by consolidating various detection modes for a wide range of assays onto one platform. For example, in February 2023, PerkinElmer Inc., a MedTech company based in the US, introduced its EnVision Nexus system. The EnVision Nexus system is recognized as the fastest and most sensitive multimode plate reader accessible, specifically engineered for rigorous high-throughput screening (HTS) applications to accelerate drug discovery initiatives. Utilizing its distinct technology, which encompasses dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, along with current reagent kits, this platform delivers unmatched assay flexibility, precision, speed, and sensitivity to researchers. Featuring convenient walkaway capabilities, including a plate stacker for 20 or 50 plates or complete automation and integration for nonstop 24/7 workflow operations, the EnVision Nexus system enables researchers to effectively screen millions of samples with exceptional efficiency.

    Which Major Industry Participants Are Leading The High Throughput Screening (HTS) Market Growth?

    Major companies operating in the high throughput screening (hts) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc.

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Which Region Is Expected To Experience The Fastest Growth In The High Throughput Screening (HTS) Market?

    North America was the largest region in the high throughput screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (hts) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized High Throughput Screening (HTS) Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2026, By The Business Research Company

    High Throughput Screening Hts Market Report 2026

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Carrier Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/carrier-screening-global-market-report

    Herg Screening Market Report 2026

    https://www.thebusinessresearchcompany.com/report/herg-screening-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • High Throughput Screening (HTS) Market 2025–2029: Tracking 8.7% CAGR Toward $35.29 Billion in Revenue

    High Throughput Screening (HTS) Market 2025–2029: Tracking 8.7% CAGR Toward $35.29 Billion in Revenue

    Uncover key drivers, emerging technologies, and competitive movements shaping the high throughput screening (hts) market from 2025–2034 with trusted insights from The Business Research Company

    How Will The High Throughput Screening (HTS) Market Size Evolve Between Now And 2029?

    The high throughput screening (hts) market size has seen substantial growth over recent years. It is projected to increase from $22.98 billion in 2024 to $25.26 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.9%. This historical growth can be attributed to several factors, including the rising adoption of high-throughput screening, increased R&D spending, enhanced availability of funds for research, growing healthcare expenditure, and a competitive market environment.

    The high throughput screening (hts) market is anticipated to show robust expansion in the forthcoming years. It is projected to reach a value of $35.29 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 8.7%. This projected increase is attributable to the expanding market and its growth momentum, strategic initiatives undertaken by major industry players, the escalating need for disease monitoring and drug discovery, the increasing incidence of chronic diseases, and an elevated emphasis on deploying ultra high throughput screening (UHTS) techniques. Significant trends during the forecast period encompass technological advancements within high-throughput screening and a sustained focus on integrating ultra high throughput screening (UHTS) techniques.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    Which Key Drivers Are Powering Growth In The High Throughput Screening (HTS) Market?

    The increasing prevalence of chronic diseases is projected to drive the expansion of the high-throughput screening (HTS) market in the future. A chronic disease is defined as a long-term health condition or ailment that persists over an extended period, typically for three months or longer. HTS enables the rapid screening of numerous chemical compounds to identify potential drug candidates targeting specific pathways or mechanisms involved in chronic diseases, which is essential for their effective long-term management. For instance, in January 2023, according to the National Library of Medicine, a US-based government agency, the number of individuals in the US aged 50 and older with at least 1 chronic condition is expected to rise to 142.66 million by 2050. Therefore, the growing prevalence of chronic diseases will propel the growth of the high-throughput screening (HTS) market.

    How Is The Global High Throughput Screening (HTS) Market Structured By Key Segments?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    What Future-Focused Trends Are Anticipated In The High Throughput Screening (HTS) Market?

    Leading companies active in the high-throughput screening market are developing innovative products, such as multimode plate readers, to better serve their clientele with advanced functionalities. A multimode plate reader (MPR) is a sophisticated laboratory instrument used in high-throughput screening, analyzing biological and chemical samples in microplates by integrating multiple detection modes for diverse assays within a single platform. For instance, in February 2023, PerkinElmer Inc., a US-based MedTech company, launched the EnVision Nexus system. The EnVision Nexus system distinguishes itself as the fastest and most sensitive multimode plate reader available, explicitly designed for demanding high-throughput screening (HTS) applications to expedite drug discovery efforts. With its unique technology, including dual detectors and optimized reagents like proprietary HTRF and AlphaLISA, coupled with the latest reagent kits, the platform offers researchers unparalleled assay flexibility, accuracy, speed, and sensitivity. Equipped with walkaway convenience options such as a plate stacker for 20 or 50 plates or full automation and integration for continuous 24/7 workflow-driven operations, the EnVision Nexus system empowers researchers to efficiently screen millions of samples with unprecedented efficiency.

    Which Companies Hold A Competitive Edge In The High Throughput Screening (HTS) Market?

    Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    Which Region Is Expected To Lead The High Throughput Screening (HTS) Market In The Next Few Years?

    North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2025, By The Business Research Company

    Prenatal Testing And Newborn Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Drug Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Employment Screening Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global High Throughput Screening (HTS) Industry Trends: Where the Market Is Headed by 2029

    Global High Throughput Screening (HTS) Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Larger Is The High Throughput Screening (HTS) Market Expected To Become By 2029 Compared With Its 2025 Level?

    The high throughput screening (hts) market has demonstrated strong growth over recent years. It is projected to expand from $22.98 billion in 2024 to $25.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%. The expansion observed in the past period can be linked to factors such as the increasing adoption of high-throughput screening, rising R&D spending, growing availability of funds for research, increasing healthcare spending, and a competitive market landscape.

    The high throughput screening (hts) market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $35.29 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is driven by factors such as an expanding market and accelerated growth rate, key players’ strategic initiatives, an escalating need for disease surveillance and pharmaceutical research, the increasing occurrence of chronic illnesses, and a heightened emphasis on adopting ultra high throughput screening (UHTS) methods. Significant trends identified for this period encompass technological progress within high-throughput screening and an increasing inclination towards utilizing ultra high throughput screening (UHTS) techniques.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    What Are The Emerging Market Drivers Creating New Opportunities In The High Throughput Screening (HTS) Industry?

    The high-throughput screening (HTS) market is anticipated to expand due to the increasing prevalence of chronic diseases in the future. A chronic disease is defined as a health condition or illness that endures for an extended duration, typically for at least three months. HTS facilitates the swift evaluation of numerous chemical compounds to identify promising drug candidates that target specific pathways or mechanisms involved in chronic conditions, which is crucial for their successful long-term treatment. For example, data from January 2023, sourced from the National Library of Medicine, a government agency in the US, indicates that the population in the US aged 50 and older suffering from at least 1 chronic condition is projected to reach 142.66 million by 2050. Consequently, the growing occurrence of chronic diseases will stimulate the expansion of the high-throughput screening (HTS) market.

    What Are The Emerging Segments Gaining Attention In The High Throughput Screening (HTS) Market?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    Which Key Trends Are Expected To Influence The High Throughput Screening (HTS) Market In The Coming Years?

    Leading firms within the high-throughput screening market are creating cutting-edge products, including multimode plate readers, to offer enhanced features and improved service to their clientele. A multimode plate reader (MPR) serves as a sophisticated laboratory instrument essential for high-throughput screening, enabling the analysis of biological and chemical samples in microplates through the integration of various detection methods for different assays on one unified platform. As an illustration, in February 2023, PerkinElmer Inc., a US-based MedTech enterprise, introduced its EnVision Nexus system. The EnVision Nexus system is recognized as the fastest and most sensitive multimode plate reader accessible, specifically engineered for rigorous high-throughput screening (HTS) applications with the goal of accelerating drug discovery processes. Utilizing its distinctive technology, which encompasses dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, alongside contemporary reagent kits, this platform provides scientists with unmatched flexibility, precision, speed, and sensitivity in their assays. Featuring hands-free operational conveniences like a plate stacker accommodating 20 or 50 plates, or full automation and integration for nonstop 24/7 workflow operations, the EnVision Nexus system allows researchers to effectively screen millions of samples with exceptional efficiency.

    Which Industry Leaders Are Driving Innovation Across The High Throughput Screening (HTS) Market?

    Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    How Does The High Throughput Screening (HTS) Market Perform Across Key Geographic Regions?

    North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The High Throughput Screening (HTS) Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2025, By The Business Research Company

    Prenatal Testing And Newborn Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Drug Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Employment Screening Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global High Throughput Screening (HTS) Industry Trends: Where the Market Is Headed by 2029

    Global High Throughput Screening (HTS) Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Larger Is The High Throughput Screening (HTS) Market Expected To Become By 2029 Compared With Its 2025 Level?

    The high throughput screening (hts) market has demonstrated strong growth over recent years. It is projected to expand from $22.98 billion in 2024 to $25.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%. The expansion observed in the past period can be linked to factors such as the increasing adoption of high-throughput screening, rising R&D spending, growing availability of funds for research, increasing healthcare spending, and a competitive market landscape.

    The high throughput screening (hts) market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $35.29 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is driven by factors such as an expanding market and accelerated growth rate, key players’ strategic initiatives, an escalating need for disease surveillance and pharmaceutical research, the increasing occurrence of chronic illnesses, and a heightened emphasis on adopting ultra high throughput screening (UHTS) methods. Significant trends identified for this period encompass technological progress within high-throughput screening and an increasing inclination towards utilizing ultra high throughput screening (UHTS) techniques.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    What Are The Emerging Market Drivers Creating New Opportunities In The High Throughput Screening (HTS) Industry?

    The high-throughput screening (HTS) market is anticipated to expand due to the increasing prevalence of chronic diseases in the future. A chronic disease is defined as a health condition or illness that endures for an extended duration, typically for at least three months. HTS facilitates the swift evaluation of numerous chemical compounds to identify promising drug candidates that target specific pathways or mechanisms involved in chronic conditions, which is crucial for their successful long-term treatment. For example, data from January 2023, sourced from the National Library of Medicine, a government agency in the US, indicates that the population in the US aged 50 and older suffering from at least 1 chronic condition is projected to reach 142.66 million by 2050. Consequently, the growing occurrence of chronic diseases will stimulate the expansion of the high-throughput screening (HTS) market.

    What Are The Emerging Segments Gaining Attention In The High Throughput Screening (HTS) Market?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    Which Key Trends Are Expected To Influence The High Throughput Screening (HTS) Market In The Coming Years?

    Leading firms within the high-throughput screening market are creating cutting-edge products, including multimode plate readers, to offer enhanced features and improved service to their clientele. A multimode plate reader (MPR) serves as a sophisticated laboratory instrument essential for high-throughput screening, enabling the analysis of biological and chemical samples in microplates through the integration of various detection methods for different assays on one unified platform. As an illustration, in February 2023, PerkinElmer Inc., a US-based MedTech enterprise, introduced its EnVision Nexus system. The EnVision Nexus system is recognized as the fastest and most sensitive multimode plate reader accessible, specifically engineered for rigorous high-throughput screening (HTS) applications with the goal of accelerating drug discovery processes. Utilizing its distinctive technology, which encompasses dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, alongside contemporary reagent kits, this platform provides scientists with unmatched flexibility, precision, speed, and sensitivity in their assays. Featuring hands-free operational conveniences like a plate stacker accommodating 20 or 50 plates, or full automation and integration for nonstop 24/7 workflow operations, the EnVision Nexus system allows researchers to effectively screen millions of samples with exceptional efficiency.

    Which Industry Leaders Are Driving Innovation Across The High Throughput Screening (HTS) Market?

    Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    How Does The High Throughput Screening (HTS) Market Perform Across Key Geographic Regions?

    North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The High Throughput Screening (HTS) Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2025, By The Business Research Company

    Prenatal Testing And Newborn Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Drug Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Employment Screening Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Global High Throughput Screening (HTS) Industry Trends: Where the Market Is Headed by 2029

    Global High Throughput Screening (HTS) Industry Trends: Where the Market Is Headed by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    How Much Larger Is The High Throughput Screening (HTS) Market Expected To Become By 2029 Compared With Its 2025 Level?

    The high throughput screening (hts) market has demonstrated strong growth over recent years. It is projected to expand from $22.98 billion in 2024 to $25.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.9%. The expansion observed in the past period can be linked to factors such as the increasing adoption of high-throughput screening, rising R&D spending, growing availability of funds for research, increasing healthcare spending, and a competitive market landscape.

    The high throughput screening (hts) market is projected to experience substantial expansion over the upcoming years. Its value is anticipated to reach $35.29 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. This anticipated growth during the forecast period is driven by factors such as an expanding market and accelerated growth rate, key players’ strategic initiatives, an escalating need for disease surveillance and pharmaceutical research, the increasing occurrence of chronic illnesses, and a heightened emphasis on adopting ultra high throughput screening (UHTS) methods. Significant trends identified for this period encompass technological progress within high-throughput screening and an increasing inclination towards utilizing ultra high throughput screening (UHTS) techniques.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=14116&type=smp

    What Are The Emerging Market Drivers Creating New Opportunities In The High Throughput Screening (HTS) Industry?

    The high-throughput screening (HTS) market is anticipated to expand due to the increasing prevalence of chronic diseases in the future. A chronic disease is defined as a health condition or illness that endures for an extended duration, typically for at least three months. HTS facilitates the swift evaluation of numerous chemical compounds to identify promising drug candidates that target specific pathways or mechanisms involved in chronic conditions, which is crucial for their successful long-term treatment. For example, data from January 2023, sourced from the National Library of Medicine, a government agency in the US, indicates that the population in the US aged 50 and older suffering from at least 1 chronic condition is projected to reach 142.66 million by 2050. Consequently, the growing occurrence of chronic diseases will stimulate the expansion of the high-throughput screening (HTS) market.

    What Are The Emerging Segments Gaining Attention In The High Throughput Screening (HTS) Market?

    The high throughput screening (hts) market covered in this report is segmented –

    1) By Products And Services: Consumables And Reagents, Instruments, Software And Services

    2) By Technology: Ultra-High-Throughput Screening, Cell-Based Assays, Lab-On-A-Chip, Label-Free Technology

    3) By Application: Target Identification And Validation, Primary And Secondary Screening, Toxicology Assessment, Other Applications

    4) By End User: Pharmaceuticals And Biotechnology Industry, Academics And Research Institute, Contract Research Organization, Other End Users

    Subsegments:

    1) By Consumables And Reagents: Assay Plates, Reagents And Assay Kits, Sample Preparation Kits, Detection Reagents

    2) By Instruments: Automated Liquid Handlers, Plate Readers, Robotics And Automation Systems, Microfluidic Devices

    3) By Software And Services: Data Analysis Software, HTS Management Software, Consulting Services, Maintenance And Support Services

    Which Key Trends Are Expected To Influence The High Throughput Screening (HTS) Market In The Coming Years?

    Leading firms within the high-throughput screening market are creating cutting-edge products, including multimode plate readers, to offer enhanced features and improved service to their clientele. A multimode plate reader (MPR) serves as a sophisticated laboratory instrument essential for high-throughput screening, enabling the analysis of biological and chemical samples in microplates through the integration of various detection methods for different assays on one unified platform. As an illustration, in February 2023, PerkinElmer Inc., a US-based MedTech enterprise, introduced its EnVision Nexus system. The EnVision Nexus system is recognized as the fastest and most sensitive multimode plate reader accessible, specifically engineered for rigorous high-throughput screening (HTS) applications with the goal of accelerating drug discovery processes. Utilizing its distinctive technology, which encompasses dual detectors and optimized reagents such as proprietary HTRF and AlphaLISA, alongside contemporary reagent kits, this platform provides scientists with unmatched flexibility, precision, speed, and sensitivity in their assays. Featuring hands-free operational conveniences like a plate stacker accommodating 20 or 50 plates, or full automation and integration for nonstop 24/7 workflow operations, the EnVision Nexus system allows researchers to effectively screen millions of samples with exceptional efficiency.

    Which Industry Leaders Are Driving Innovation Across The High Throughput Screening (HTS) Market?

    Major companies operating in the high throughput screening (HTS) market are Thermo Fisher Scientific Inc., AstraZeneca Plc, Danaher Corporation, Merck Group, GE HealthCare Technologies Inc., Corning Inc., Agilent Technologies Inc., Lonza Group Ltd., Charles River Laboratories International Inc, Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories, Tecan Group Ltd., Sygnature Discovery Ltd., Luminex Corporation, Hamilton Company, Crown Bioscience Inc., HighRes Biosolutions, NanoTemper Technologies GmbH, BMG LABTECH GmbH, Axxam SpA, Reprocell Inc., BioTek Instruments Inc, Aurora Biomed Inc., Cyclica Inc., Biomat Srl, Diana Biotechnologies s.r.o

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/high-throughput-screening-hts-global-market-report

    How Does The High Throughput Screening (HTS) Market Perform Across Key Geographic Regions?

    North America was the largest region in the high throughput screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high throughput screening (HTS) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Version Of The High Throughput Screening (HTS) Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=14116&type=smp

    Browse Through More Reports Similar to the Global High Throughput Screening (HTS) Market 2025, By The Business Research Company

    Prenatal Testing And Newborn Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

    Drug Screening Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

    Employment Screening Services Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/employment-screening-services-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model